(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and inhibits two key aggregation-promoting hotspots of the Tau protein, which is critical … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Alzheimer's Treatments, dementia, Dr Richard Oakley, Dr. Anthony Aggidis, Peptide Inhibitor, Professor Amritpal Mudher, RI-AG03, Tau Protein, University of Southampton
(IN BRIEF) A recent study led by Queen Mary University of London, in collaboration with the University of Exeter, highlights the efficacy of a new therapy called NIDUS-Family in assisting individuals with dementia and their family carers in achieving their … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Non Profit, Science, United Kingdom
Tagged Dr Iain Lang, Dr Richard Oakley, Helping, NIDUS-Family Therapy, partnership, people with dementia, Professor Claudia Cooper, Professor Martin Knapp, Queen Mary University of London, sustainability, University of Exeter
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?